Would President Obama kill drug development?

Tuesday, November 4th, 2008

He would, suggests Charles Hooper at Forbes.com.  Some selections: Say a biotech company is developing a new drug for breast cancer. My consulting firm, Objective Insights, looks at the financial value of the project. If the expected value--probability-adjusted value--of the project is negative, we suggest discontinuing development. Often, millions of dollars ...

Posted in prescription drugs | No Comments »

British National Health Service denies care

Thursday, May 22nd, 2008

From the Daily Mail : How the NHS is letting my father die - by a top hospital consultant by Sarah Anderson Eye specialist Sarah Anderson works at York Hospital . Her father Ian has been refused Sutent, a new cancer drug, which could provide the only real chance of prolonging his life. ...

Posted in coverage is not care, single payer | No Comments »